Tarkus
The number of National Certificate of Registration: 77.99.23.3.U.2126.3.09 dated March 13, 2009 Specification number: TU 9283-008-59230155-09 Formulation: “Dienai C” (salmon roe extract (low-molecular DNA), potato starch, microcrystalline cellulose, sodium chloride, polyethylene glycol), “Maristim C” (hydrolysate of squid ganglia). Pharmacological group: refers to the group of food supplements-parapharmaceutics. Toxicologic characteristics: This preparation refers to class 4 (“low-hazard substances”) according to Russian Interstate Standard 12.1.007-76. No toxic or side effects were revealed after the experimental intragastral administration to animals. Indications: biocorrection of male chronic inflammatory diseases, male sterility, impotence, metabolic syndrome; the extract is used for prevention and treatment of oncological diseases, depresses the growth of malignant formations of any location, highly efficient for patients with pre-cancerous condition. The preparation has shown exclusive results for treatment of cardiovascular diseases, diabetes mellitus, cerebropathy, chronic diseases of liver and kidneys, intestine, thyroid body, respiratory and musculoskeletal systems, and gynecological diseases. The preparation is also known as an antiviral agent that is effective for fight against gastric parasites. Administration method and dosage: orally, 1 capsule three times a day during the meal to adults and children older than 14 years. Administration duration is three weeks. Contraindications: individual intolerance for preparation components, pregnancy, lactation, gout, and other abnormalities in purine exchange (hyperuricemy, urine acid diathesis, urate nephrolithiasis). Pharmaceutical form: 0.5 g capsules, 30 per package. Storing conditions: store in a dry place away from light, out of the reach of children at temperature up to 25 oC. Expiration date: 12 months from the date of manufacturing. Prescription conditions: No prescription required. Manufacturer: Siberian Center for Pharmacology and Biotechnology, closed joint-stock company (Novosibirsk, Russian Federation).
|
